Eric Richman Insider Profile

11 Followers
Eric Richman, Director at Altimmune, holds 63.83K shares in NeuBase Therapeutics (Ticker: NBSE), holds 44.03K shares in ADMA Biologics (Ticker: ADMA), holds 186.82K shares in Altimmune (Ticker: ALT). Most recently, Eric Richman Bought ― shares of NeuBase Therapeutics on May 04, 2020 for an estimated value of 65.00K.
tipranks
Eric Richman

Eric Richman
Altimmune (ALT)
Director

Ranked #3,663 out of 78,624 Corporate Insiders

Profitable Transactions

42%
5 out of 12 Profitable Transactions

Average Return

+32.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
77.36%
19.35%
3.29%
A breakdown of Eric Richman's holdings

Insider Roles

Altimmune
(ALT)
Director
NeuBase Therapeutics
(NBSE)
Director
ADMA Biologics
(ADMA)
Director
Roles that Eric Richman holds in companies

Most Profitable Insider Trade

Stock:
Altimmune
(ALT)
Rating:Informative Buy
Date:Apr 11, 2016 - Apr 11, 2017
Return:+199.80%
The most profitable trade made by Eric Richman

Eric Richman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Altimmune
Nov 23, 2016
Director
Informative Buy
895.21K
$1.97M
NeuBase Therapeutics
May 04, 2020
Director
Informative Buy
65.00K
$491.47K
ADMA Biologics
Mar 03, 2020
Director
Uninformative Buy
$83.66K
List of latest transactions for each holding click on a transaction to see Eric Richman's performance on stock

Eric Richman insider profile FAQ

What is the percentage of profitable transactions made by Eric Richman?
The percentage of profitable transactions made by Eric Richman is 42%.
    What is the average return per transaction made by Eric Richman?
    The average return per transaction made by Eric Richman is 32.90%.
      What stocks does Eric Richman hold?
      Eric Richman holds: ALT, NBSE, ADMA stocks.
        What was Eric Richman’s latest transaction?
        Eric Richman latest transaction was an Informative Buy of $65.00K.
          What was Eric Richman's most profitable transaction?
          Eric Richman’s most profitable transaction was an Informative Buy of ALT stock on April 11, 2016. The return on the trade was 199.80%.
            What is Eric Richman's role in Altimmune?
            Eric Richman's role in Altimmune is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.